6MD vs NOVN: Side-by-Side Comparison
Compare MEDACTA GROUP S.A. SF-,10 (6MD) and Novartis AG (NOVN) side by side: market cap EUR 2.81B vs CHF 244.54B, P/E 29.5 vs 22.7. Financials, growth and model signals on Bullrun.
| Metric | 6MD | NOVN |
|---|---|---|
| Company | MEDACTA GROUP S.A. SF-,10 | Novartis AG |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Drug Manufacturers - General |
| Market cap | EUR 2.81B | CHF 244.54B |
| P/E ratio | 29.5 | 22.7 |
| Dividend yield | 0.81% | 2.96% |
| Valuation model | — | 6.8% undervalued |
| Revenue (latest FY) | EUR 683.83M | — |
| Revenue growth YoY | +15.8% | — |
| Net income | EUR 95.46M | — |
| Gross margin | 67.1% | — |
| Diluted EPS | — | — |